• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMV
Click for more information
0.00% $1.97

EMVISION MEDICAL DEVICES LTD

Market Cap $167.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

EMVision Medical Devices Limited is an Australia-based medical device company developing... EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company’s product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMV
Chart
46 47 48
09:49 2.8K 1.5M
09:49 Last post  vintage Comments Created with Sketch.  2.8K  Views Created with Sketch.  1.5M 
EMV
EMvision Research Notes
41 42 43
27/06/24 2.5K 1.2M
27/06/24 Last post  vintage Comments Created with Sketch.  2.5K  Views Created with Sketch.  1.2M 
EMV
Ann: Pilot Production Line Established & $1.25m Grant Received 		25/06/24 45 10K
25/06/24 Last post  vintage Comments Created with Sketch.  45  Views Created with Sketch.  10K 
EMV
Ann: Trial data confirms early ischaemia detection capabilities 		01/06/24 21 8.3K
01/06/24 Last post  chaddy36 Comments Created with Sketch.  21  Views Created with Sketch.  8.3K 
EMV
Ann: Strategic A$15.28M Investment from Keysight Technologies 		26/05/24 45 18K
26/05/24 Last post  vmos Comments Created with Sketch.  45  Views Created with Sketch.  18K 
EMV
Ann: Australian Stroke Alliance & FDA Update
2 3 4
22/05/24 215 86K
22/05/24 Last post  vintage Comments Created with Sketch.  215  Views Created with Sketch.  86K 
EMV
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability 		09/05/24 51 19K
09/05/24 Last post  BuffettWarren Comments Created with Sketch.  51  Views Created with Sketch.  19K 
EMV
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		26/04/24 11 4.7K
26/04/24 Last post  Michaelirish Comments Created with Sketch.  11  Views Created with Sketch.  4.7K 

See All Discussions arrow Created with Sketch.

Timeline

Pilot Production Line Established & $1.25m Grant Received
24 Jun 08:15
 
Trial data confirms early ischaemia detection capabilities
27 May 08:24
 
Notification of cessation of securities - EMV
26 Apr 08:26
 
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 08:44
 
Stage 2 Insights Confirm Diagnostic & Clinical Viability
27 Mar 09:07
 
ASA Milestone Achieved for $0.6m Grant Payment
13 Mar 09:00
 
View More arrow Created with Sketch.

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.

(20min delay)
Last
$1.97 		Change
0.000(0.00%) 		Mkt cap ! $167.8M
Open High Low Value Volume
$2.00 $2.01 $1.97 $22.27K 11.16K

Buyers (Bids)

No. Vol. Price($)
1 2631 $1.90
 

Sellers (Offers)

Price($) Vol. No.
$2.03 5163 2
View Market Depth
Last trade - 10.33am 03/07/2024 (20 minute delay) ?
Last
$1.97 		  Change
0.000 ( 0.13 %)
Open High Low Volume
$2.02 $2.02 $1.97 652
Last updated 10.33am 03/07/2024 ?
EMV (ASX) Chart

Top Stories

Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4

Ark Mines has published an Exploration Target for its Sandy Mitchell REE project of up to 1.5B tonnes @ up to 1490ppm monazite equivalent
Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project  The company has locked in a drilling contractor to fire up a Reverse Circulation (RC) drill rig at Maverick starting on 8th of July US time. 
Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25 Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.
Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76% Sovereign Metals Ltd has seen a boost to its Kasiya rutile graphite project in Malawi, as Rio Tinto increases its interest in the company.
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.